These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31624046)

  • 1. Frontline therapy in multiple myeloma: fast start for a long game.
    Patriarca F
    Lancet Haematol; 2019 Dec; 6(12):e600-e601. PubMed ID: 31624046
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of transplant-eligible symptomatic multiple myeloma].
    Nakaseko C
    Rinsho Ketsueki; 2014 Oct; 55(10):2016-26. PubMed ID: 25297767
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment Intensification With Autologous Stem Cell Transplantation and Lenalidomide Maintenance Improves Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma in Complete Response.
    Mina R; Petrucci MT; Corradini P; Spada S; Patriarca F; Cerrato C; De Paoli L; Pescosta N; Ria R; Malfitano A; Musto P; Baldini L; Guglielmelli T; Gamberi B; Mannina D; Benevolo G; Zambello R; Falcone AP; Palumbo A; Nagler A; Calafiore V; Hájek R; Spencer A; Boccadoro M; Bringhen S
    Clin Lymphoma Myeloma Leuk; 2018 Aug; 18(8):533-540. PubMed ID: 29910180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should the emphasis be on induction or consolidation therapy in transplant-eligible, newly diagnosed multiple myeloma?
    Krishnan A; Sonneveld P
    Lancet Haematol; 2020 Jun; 7(6):e445-e446. PubMed ID: 32470436
    [No Abstract]   [Full Text] [Related]  

  • 5. VI. Autologous stem cell transplantation and maintenance therapy.
    Moreau P
    Hematol Oncol; 2013 Jun; 31 Suppl 1():42-6. PubMed ID: 23775648
    [No Abstract]   [Full Text] [Related]  

  • 6. Consolidation and maintenance therapy for multiple myeloma after autologous transplantation: where do we stand?
    Mohty M; Richardson PG; McCarthy PL; Attal M
    Bone Marrow Transplant; 2015 Aug; 50(8):1024-9. PubMed ID: 25893452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal maintenance and consolidation therapy for multiple myeloma in actual clinical practice.
    Lee HS; Min CK
    Korean J Intern Med; 2016 Sep; 31(5):809-19. PubMed ID: 27604793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting).
    Bruno B; Auner HW; Gahrton G; Garderet L; Festuccia M; Ladetto M; Lemoli RM; Massaia M; Morris C; Palumbo A; Schönland S; Boccadoro M; Kröger N
    Leuk Lymphoma; 2016; 57(6):1256-68. PubMed ID: 26735310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttransplantation maintenance therapy and optimal frontline therapy in myeloma.
    Reece DE
    Hematology Am Soc Hematol Educ Program; 2011; 2011():197-204. PubMed ID: 22160034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma.
    Salwender H; Bertsch U; Weisel K; Duerig J; Kunz C; Benner A; Blau IW; Raab MS; Hillengass J; Hose D; Huhn S; Hundemer M; Andrulis M; Jauch A; Seidel-Glaetzer A; Lindemann HW; Hensel M; Fronhoffs S; Martens U; Hansen T; Wattad M; Graeven U; Munder M; Fenk R; Haenel M; Scheid C; Goldschmidt H
    BMC Cancer; 2019 May; 19(1):504. PubMed ID: 31138244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of consolidation therapy in transplant eligible multiple myeloma patients.
    Cavo M; Brioli A; Tacchetti P; Zannetti BA; Mancuso K; Zamagni E
    Semin Oncol; 2013 Oct; 40(5):610-7. PubMed ID: 24135406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous transplantation and maintenance therapy in multiple myeloma.
    Palumbo A; Cavallo F; Gay F; Di Raimondo F; Ben Yehuda D; Petrucci MT; Pezzatti S; Caravita T; Cerrato C; Ribakovsky E; Genuardi M; Cafro A; Marcatti M; Catalano L; Offidani M; Carella AM; Zamagni E; Patriarca F; Musto P; Evangelista A; Ciccone G; Omedé P; Crippa C; Corradini P; Nagler A; Boccadoro M; Cavo M
    N Engl J Med; 2014 Sep; 371(10):895-905. PubMed ID: 25184862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing therapy for transplant-eligible patients with newly diagnosed multiple myeloma.
    Moreau P; Giralt SA
    Leuk Res; 2012 Nov; 36 Suppl 1():S13-8. PubMed ID: 23176719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma.
    Einsele H; Knop S; Vogel M; Müller J; Kropff M; Metzner B; Langer C; Sayer H; Jung W; Dürk HA; Salwender H; Wandt H; Bassermann F; Gramatzki M; Rösler W; Wolf HH; Brugger W; Engelhardt M; Fischer T; Liebisch P; Straka C
    Leukemia; 2017 Jun; 31(6):1463-1466. PubMed ID: 28293022
    [No Abstract]   [Full Text] [Related]  

  • 15. The roles of consolidation and maintenance therapy with novel agents after autologous stem cell transplantation in patients with multiple myeloma.
    Joks M; Jurczyszyn A; Machaczka M; Skotnicki AB; Komarnicki M
    Eur J Haematol; 2015 Feb; 94(2):109-14. PubMed ID: 25039659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical treatment of newly diagnosed multiple myeloma.
    Cejalvo MJ; de la Rubia J
    Expert Rev Hematol; 2015 Oct; 8(5):595-611. PubMed ID: 26327587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of autologous bone marrow transplant in multiple myeloma.
    Blanes M; de la Rubia J
    Curr Opin Oncol; 2012 Nov; 24(6):733-41. PubMed ID: 23079784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance therapy for multiple myeloma.
    McCarthy PL; Palumbo A
    Hematol Oncol Clin North Am; 2014 Oct; 28(5):839-59. PubMed ID: 25212886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Front-line transplantation program with lenalidomide, bortezomib, and dexamethasone combination as induction and consolidation followed by lenalidomide maintenance in patients with multiple myeloma: a phase II study by the Intergroupe Francophone du Myélome.
    Roussel M; Lauwers-Cances V; Robillard N; Hulin C; Leleu X; Benboubker L; Marit G; Moreau P; Pegourie B; Caillot D; Fruchart C; Stoppa AM; Gentil C; Wuilleme S; Huynh A; Hebraud B; Corre J; Chretien ML; Facon T; Avet-Loiseau H; Attal M
    J Clin Oncol; 2014 Sep; 32(25):2712-7. PubMed ID: 25024076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. United Kingdom Myeloma Forum position statement on the use of consolidation and maintenance treatment in myeloma.
    Rabin N; Lai M; Pratt G; Morgan G; Snowden J; Bird J; Cook G; Bowcock S; Owen R; Yong K; Wechalaker A; Low E; Davies F;
    Int J Lab Hematol; 2014 Dec; 36(6):665-75. PubMed ID: 24673823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.